1. Design, Synthesis and Evaluation of a Series of 1,5‐Diaryl‐1,2,3‐triazole‐4‐carbohydrazones as Inhibitors of the YAP‐TAZ/TEAD Complex
- Author
-
Ajaybabu V. Pobbati, Martine Pugnière, Ashley Burtscher, Patricia Melnyk, Fabrice Bailly, Brian P. Rubin, Frédéric Allemand, Manon Sturbaut, Philippe Cotelle, Jean-François Guichou, Floriane Gibault, Wanjin Hong, and Mathilde Coevoet
- Subjects
1,2,3-Triazole ,Cell Survival ,Antineoplastic Agents ,Biochemistry ,Fluorescence spectroscopy ,Protein–protein interaction ,Structure-Activity Relationship ,chemistry.chemical_compound ,Drug Discovery ,Humans ,Cytotoxic T cell ,General Pharmacology, Toxicology and Pharmaceutics ,Cells, Cultured ,Cell Proliferation ,Pharmacology ,Reporter gene ,Hippo signaling pathway ,Dose-Response Relationship, Drug ,Molecular Structure ,Chemistry ,Organic Chemistry ,HEK 293 cells ,Hydrazones ,TEA Domain Transcription Factors ,YAP-Signaling Proteins ,Triazoles ,HEK293 Cells ,Drug Design ,Transcriptional Coactivator with PDZ-Binding Motif Proteins ,Molecular Medicine ,Drug Screening Assays, Antitumor ,Fluorescence anisotropy - Abstract
Starting from our previously reported hit, a series of 1,5-diaryl-1,2,3-triazole-4-carbohydrazones were synthesized and evaluated as inhibitors of the YAP/TAZ-TEAD complex. Their binding to hTEAD2 was confirmed by nanodifferential scanning fluorimetry, and some of the compounds were also found to moderately disrupt the YAP-TEAD interaction, as assessed by a fluorescence polarization assay. A TEAD luciferase gene reporter assay performed in HEK293T cells and RTqPCR measurements in MDA-MB231 cells showed that these compounds inhibit YAP/TAZ-TEAD activity to cells in the micromolar range. In spite of the cytotoxic effects displayed by some of the compounds of this series, they are still good starting points and can be suitably modified into an effective and viable YAP-TEAD disruptor in the future.
- Published
- 2021
- Full Text
- View/download PDF